Driehaus Capital Management LLC Vericel Corp Transaction History

Driehaus Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$7.25 - $19.22 $3.23 Million - $8.56 Million	-445,475 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$13.77 - $19.2 $6.36 Million - $8.87 Million	-461,829 Reduced 50.9%	445,475 $7.75 Million
Q3 2019 Nov 14, 2019	SELL	$14.93 - $19.83 $3.73 Million - $4.95 Million	-249,751 Reduced 21.59%	907,304 $13.7 Million
Q2 2019 Aug 14, 2019	BUY	$15.01 - $18.89 $108,132 - $136,083	7,204 Added 0.63%	1,157,055 $21.9 Million
Q1 2019 May 15, 2019	BUY	$16.23 - $20.29 $867,639 - $1.08 Million	53,459 Added 4.88%	1,149,851 $20.1 Million
Q4 2018 Feb 14, 2019	BUY	$10.77 - $18.44 $5.22 Million - $8.94 Million	484,840 Added 79.28%	1,096,392 $19.1 Million
Q3 2018 Nov 14, 2018	SELL	$9.1 - $14.8 $2.15 Million - $3.49 Million	-235,939 Reduced 27.84%	611,552 $8.65 Million
Q2 2018 Aug 14, 2018	BUY	$9.6 - $14.6 $5.27 Million - $8.01 Million	548,474 Added 183.43%	847,491 $8.22 Million
Q1 2018 May 15, 2018	BUY	$5.7 - $12.3 $1.7 Million - $3.68 Million	299,017 New	299,017 $2.98 Million

276

48.8M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.79B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.